Opioid Use Disorder in the Emergency Department: CTN 0069
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Opioid Use Disorder
Related studies linked through entity extraction aliases.
Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Single Ascending Dose Study of RBP-6000
- Status
- COMPLETED
- Phase
- PHASE1
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
- Status
- COMPLETED
- Phase
- NA
Open-Label Treatment Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Screening in Trauma for Opioid Misuse Prevention
- Status
- COMPLETED
- Phase
- N/A
MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence
- Status
- COMPLETED
- Phase
- NA
Single-dose, Study of RBP-6000 in Opioid Dependent Individuals
- Status
- COMPLETED
- Phase
- PHASE1
TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051
- Status
- COMPLETED
- Phase
- N/A
Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth
- Status
- COMPLETED
- Phase
- NA
Phase II Pharmacokinetics Study of CAM2038
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
- Status
- COMPLETED
- Phase
- PHASE3
NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans
- Status
- COMPLETED
- Phase
- NA
Medication-Assisted Treatment for Youth With Substance Use Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
- Status
- COMPLETED
- Phase
- PHASE1
Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial
- Status
- COMPLETED
- Phase
- NA